Mutation in Genes FBN1, AKT1, and LMNA: Marfan Syndrome, Proteus Syndrome, and Progeria Share Common Systemic Involvement
Keywords:Genetic mutation, Marfan syndrome, Proteus syndrome, Progeria, Gene FBN1, Gene AKT1, Gene LMNA, Musculo-skeletal system, Cardiovascular system, Eye, Nervous system
Genetic mutations are becoming more deleterious day by day. Mutations of Genes named FBN1, AKT1, LMNA result specific protein malfunction that in turn commonly cause Marfan syndrome, Proteus syndrome, and Progeria, respectively. Articles about these conditions have been reviewed in PubMed and Google scholar with a view to finding relevant clinical features. Precise keywords have been used in search for systemic involvement of FBN1, AKT1, and LMNA gene mutations. It has been found that Marfan syndrome, Proteus syndrome, and Progeria commonly affected musculo-skeletal system, cardiovascular system, eye, and nervous system. Not only all of them shared identical systemic involvement, but also caused several very specific anomalies in various parts of the body. In spite of having some individual signs and symptoms, the mutual manifestations were worth mentioning. Moreover, all the features of the mutations of all three responsible genes had been co-related and systemically mentioned in this review. There can be some mutual properties of the genes FBN1, AKT1, and LMNA or in their corresponding proteins that result in the same presentations. This study may progress vision of knowledge regarding risk factors, patho-physiology, and management of these conditions, and relation to other mutations.
2. Laurence Loewe. Genetic Mutation: Nature Education; Citation: Loewe, L. Genetic mutation. Nature Education-2008; 1(1):113 3. Eyre-Walker, A., Keightley. The distribution of fitness effects of new mutations. NatRev Genet.2007 Aug; 8, 610–18
4. Sawyer SA, Parsch J, Zhang Z, Hartl DL. "Prevalence of positive selection among nearly neutral amino acid replacements in Drosophila". Proc. Natl. Acad. Sci. U.S.A. (2007) 104 (16): 6504–10.
5. Mark P. Miller, Sudhir Kumar. Understanding human disease mutations through the use of interspecific genetic variation. Oxford Journals; Hum. Mol. Genet. (2001) 10 (21): 2319-2328.
6. Chen JM1, Férec C, Cooper DN. Revealing the human mutome. Clin Genet. 2010 Oct;78(4):310-20.
7. Cooper DN1, Chen JM, Ball EV, Howells K. Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat. 2010 Jun;31(6):631-55.
8. Peter D. Stenson, Matthew Mort, Edward V. Ball, Katy Shaw, Andrew D. Phillips, and David N. Cooper et al. The Human Gene Mutation Database:
building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine; Hum Genet. 2014; 133: 1–9.
9. Elizabeth A. Putnam, Hui Zhang, Francesco Ramirez & Dianna M. Milewicz. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly; Nature Genetics 11, 456 - 458 (1995)
10. Biery NJ, Eldadah ZA, Moore CS, Stetten G, Spencer F, Dietz HC. "Revised genomic organization of FBN1 and significance for regulated gene expression". Genomics (May, 1999) 56 (1): 70–7.
11. Handford PA; "Fibrillin-1, a calcium binding protein of extracellular matrix". Biochim. Biophys. Acta (2001). 1498 (2–3): 84–90. PMID 11108952
12. LMNA lamin A/C [Homo sapiens (human)]; Gene ID: 4000, updated on 13-Apr-2014; NCBI.
13. Reimer Stick. The gene structure of Xenopus nuclear lamin A: A model for the evolution of A-type from B-type lamins by exon shuffling; Springer-verlag; Chromosoma; August 1992, Volume 101, Issue 9, pp 566-574
14. P. Robinson and M. Godfrey. The molecular genetics of Marfan syndrome and related microfibrillopathies; Med Genet. Jan 2000; 37(1): 9–25. PMCID: PMC1734449
15. Wilson BT1, Jensen SA, McAnulty CP, Brennan P, Handford PA. Juvenile idiopathic arthritis, mitral valve prolapse and a familial variant involving the integrin-binding fragment of FBN1. Am J Med Genet A. 2013 Aug; 161A(8):2047-51. 16. K Shoji, K Oda, S Nakagawa, S Hosokawa. The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas; British Journal of Cancer (2009) 101, 145–148.
17. J M Askham, F Platt, P A Chambers, H Snowden, C F Taylor and M A Knowles. AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K; Oncogene (2010) 29, 150–155
18. Natasha Rekhtman, Paul K. Paik, Maria E. Arcila. Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations; Clin Cancer Res February 15, 2012,18;1167
19. Julio C. Ricarte-Filho, Mabel Ryder, Dhananjay A. Chitale, Michael Rivera. Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine- Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1; Cancer Res June 1, 2009 69; 4885
20. M S Kim, E G Jeong, N J Yoo and S H Lee. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias; British Journal of Cancer (2008) 98, 1533–1535.
21. Capell BC, Collins FS. "Human laminopathies: nuclei gone genetically awry". Nat. Rev. Genet. (December 2006). 7 (12): 940–52.
22. Rankin J, Ellard S. "The laminopathies: a clinical review". Clin. Genet. (October 2006). 70 (4): 261–74.
23. Van de Velde, S; Fillman, R; Yandow, S. Abstract of "Protrusio acetabuli in Marfan syndrome. History, diagnosis, and treatment.". The Journal of bone and joint surgery. American volume (March 2006) 88 (3): 639–46.
24. Lesley C. Adès, Darshikka, Sreetharan, Ella Onikul, Vivienne Stockton, Karen C, Watson et al. Segregation of a novel FBN1 gene mutation, G1796E, with kyphoscoliosis and radiographic evidence of vertebral dysplasia in three generations; Amer. Jour. Mol. Gen. First published online: 27 MAR 2002; DOI: 10.1002/ajmg.10333
25. Van de Velde S, Fillman R, Yandow S. Protrusio acetabuli in Marfan syndrome. History, diagnosis, and treatment; J Bone Joint Surg Am. 2006 Mar;88(3):639-46.
26. Kohlmeier L, Gasner C, Bachrach LK, Marcus R. "The bone mineral status of patients with Marfan syndrome". Journal of Bone and Mineral Research (October 1995) 10 (10): 1550–1555. PMID 8686512
27. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010 Jul;47(7):476-85.
28. Francesco Ramirez, Harry C Dietz; Marfan syndrome: from molecular pa¬thogenesis to clinical treatment Curr. Opin. Genet. Dev. 17 (2007) 252–258
29. Maria Nataatmadja, Malcolm West, Jenny West, RN; Kim Summers. Abnor¬mal Extracellular Matrix Protein Transport Associated With Increased Apopto¬sis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm; Circulation. 2003; 108: II-329-II-334.
30. P E. M. Azouz, T. Costa, N. Fitch. Radiologic findings in the proteus syndro¬me; Pediatric Radiology; October 1987, Volume 17, Issue 6, pp 481-485; Print ISSN: 0301-0449. Online ISSN: 1432-1998
31. M. Michael Cohen Jr. Proteus syndrome: An update; American Journal of Medical Genetics Part C: Seminars in Medical Genetics; Special Issue: Over¬growth Syndrome: An Update; (August 2005) 137C- 1- 38–52
32. J A R Tibbles, M M Cohen Jr. The Proteus syndrome: the Elephant Man diagnosed; British Medical Journal; SEP, 1986; VOLUME 293 13
33. Carlos A. Jamis-Dow, Joyce Turner, Leslie G. Biesecker, and Peter L. Choyke et al. Radiologic Manifestations of Proteus Syndrome; Radiological Society of North America; July 2004; 24: 4
34. Joyce T. Turner, M. Michael Cohen Jr and Leslie G. Biesecker. Reassessment of the Proteus syndrome literature: Application of diagnostic criteria to pu¬blished cases. American Journal of Medical Genetics Part A; (October 2004): 130A: 2: (111–122).
35. B. Newman, A. H. Urbach, D. Orenstein, P. S. Dickmann. Proteus syndro¬me: emphasis on the pulmonary manifestations: Pediatric Radiology; (June 1994): 24: 3: (189-193)
36. Teresa Costa, Naomi Fitch, E. Michael Azouz. Proteus Syndrome: Report of Two Cases With Pelvic Lipomatosis; Official journal of the American Academy of Pediatrics; Pediatrics Vol. 76 No. 6 December 1, 1985 pp. 984 -989
37. Raoul C.M. Hennekam. Hutchinson–Gilford progeria syndrome: Review of the phenotype; American Journal of Medical Genetics Part A; Special Issue: Thirteenth Annual Robert J. Gorlin Conference on Dysmorphology; Facial and Oral Structures: Molecular Perspectives; (December 2006) Volume 140A, Issue 23, pages 2603–2624.
38. Giselle Helena de Paula Rodriguesa, Izilda das Eiras Tâmegaa, Gusta¬vo Duqueb, Vicente Spinola Dias Netoa. Severe bone changes in a case of Hutchinson–Gilford syndrome; Annales de Génétique; Volume 45, Issue 3, July–September 2002, Pages 151–155
39. Melissa A. Merideth, Leslie B. Gordon, Sarah Clauss. Phenotype and Cour¬se of Hutchinson–Gilford Progeria Syndrome; N Engl J Med 2008; 358:592-604.
40. Leslie B. Gordon, Kathleen M. McCarten, Anita Giobbie-Hurder. Disease Progression in Hutchinson-Gilford Progeria Syndrome: Impact on Growth and Development; Official journal of the American Academy of Pediatrics; Pedia¬
trics (October 1, 2007) Vol. 120 No. 4 pp. 824 -833
41. P K Sarkara, R A Shintonb. Review: Hutchinson-Guilford progeria syndro¬me; Postgrad Med J 2001;77:312-317
42. Jinqiu Zhang, Qizhou Lian, Guili Zhu, Fan Zhou, Lin Sui, Cindy Tan. A Human iPSC Model of Hutchinson Gilford Progeria Reveals Vascular Smooth Muscle and Mesenchymal Stem Cell Defects; Cell stem cell; (7 January 2011) 8- 1: 31–45
43. Janbernd Kirschner, Thomas Brune, Manfred Wehnert, Jonas Denecke. p.S143F mutation in lamin A/C: A new phenotype combining myopathy and progeria; Annals of Neurology; (Jan 2005) Volume 57, Issue 1, pages 148–151.
44. Iannello S, Spina M, Prestipino M, Strano AM, Bellassai M, Politi G, Belfiore F. Familial Marfan's syndrome. A critical review and presentation of a clinical case; Minerva Med. 1996 May;87(5):217-35.
45. von Kodolitsch Y, Raghunath M, Nienaber CA. Marfan syndrome: preva¬lence and natural course of cardiovascular manifestations; Z Kardiol. 1998 Mar;87(3):150-60
46. Jason B. Wheeler, John S. Ikonomidis, Jeffrey A. Jones. Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Trans¬forming Growth Factor-Beta Signaling; Advances in Experimental Medicine and Biology Volume 802, 2014, pp 107-127
47. Nagesh CM, Patra S, Singh A, Badnur SC, Reddy B, Nanjappa MC. A patient with Marfan's syndrome presented with severe rheumatic mitral stenosis and successfully treated with percutaneous transmitral balloon commissuro¬tomy - Report of first case; J Cardiovasc Dis Res. 2013 Dec;4(4):257-9.
48. Bruno L, Tredici S, Mangiavacchi M, Colombo V, Mazzotta GF, Sirtori CR. Cardiac, skeletal, and ocular abnormalities in patients with Marfan's syn¬drome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis; Br Heart J. 1984 Feb;51(2):220-30.
49. De Backer J. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype. Verh K Acad Geneeskd Belg. 2009;71(6):335-71. PMID: 20232788;
50. Zipes, Libby Bonow Braunwald. Braunwald's Heart Disease ~ A Textbook of Cardiovascular Medicine, Seventh Edition. United States of America: Else¬view Saunders. (2005) p. 1894. ISBN 0-7216-0509-5.
51. Figueiredo S, Martins E, Lima MR, Alvares S.. Cardiovascular manifesta¬tions in Marfan syndrome; Rev Port Cardiol. 2001 Dec;20(12):1203-18.
52. J. Lamont Murdoch, Bryan A. Walker, Barry L. Halpern, Jan W. Kuzma, and Victor A. McKusick. Life Expectancy and Causes of Death in the Marfan Syndrome; N Engl J Med 1972; 286:804-808 April 13, 1972
53. Tracie E. Bunton, Nancy Jensen Biery, Loretha Myers, Barbara Gayraud, Francesco Ramirez, Harry C. Dietz. Phenotypic Alteration of Vascular Smooth Muscle Cells Precedes Elastolysis in a Mouse Model of Marfan Syndrome; Circulation Research. 2001; 88: 37-43
54. Takashi Haruki, Hiroshi Ito, Kensuke Sakata, Yurio Kobayashi et al. Bila¬teral axillary artery aneurysms after Bentall procedure in Marfan syndrome; Published online before print April 14, 2014. Asian Cardiovascular and Thora¬cic Annals April 14, 2014: 0218492314532278
55. Ertan Mayatepek, Thaddeus W. Kurczynski, Elizabeth S. Ruppert, James R. Hennessy, Ray A. Brinker and Beatrice N. French. Expanding the phenotype of the Proteus syndrome: A severely affected patient with new findings; American Journal of Medical Genetics; (March 1989) Volume 32, Issue 3, pa¬ges 402–406
56. Loffroy R, Rao P, Steinmetz E, Krausé D. Endovascular treatment of dis¬seminated complex aortic vascular malformations in a patient with proteus syndrome. Ann Thorac Surg. 2010 Nov;90(5):e78. doi: 10.1016/j.athorac¬sur.2010.06.122.
57. Shaw C, Bourke J, Dixon J. Proteus syndrome with cardiomyopathy and a myocardial mass. Am J Med Genet. 1993 Apr 15;46(2):145-8.
58. B. Newman, A. H. Urbach, D. Orenstein, P. S. Dickman. Proteus syndrome: emphasis on the pulmonary manifestations; Pediatric Radiology; June 1994, Volume 24, Issue 3, pp 189-193
59. Badia MC, Chamarro R, Làinez JM, Piera A. Proteus syndrome with cere¬bral vascular malformations; Neurologia. 2006 Mar;21(2):88-91.
60. Hoeger PH, Martinez A, Maerker J, Harper JI. Vascular anomalies in Pro¬teus syndrome; Clin Exp Dermatol. 2004 May;29(3):222-30.
61. QI Ying Chun and XIE Xiao Hua. Hutchinson-Gilford Progeria Syndrome and its Relevance to Cardiovascular Diseases and Normal Aging; Biomedical and Environmental Sciences (besjournal.com); doi: 10.3967/0895-3988.2013.05.007
62. Brian C. Capell, Francis S. Collins, Elizabeth G. Nabel. Mechanisms of Car¬diovascular Disease in Accelerated Aging Syndromes; Circulation Research; 2007; 101: 13-26
63. Baker PB, Baba N, Boesel CP. Cardiovascular abnormalities in progeria. Case report and review of the literature; Archives of Pathology & Laboratory Medicine [1981, 105(7):384-386; (PMID:6894691)
64. Ilyas S, Ilyas H, Hameed A, Ilyas M. Progeria syndrome with cardiac com¬plications. J Pak Med Assoc. 2013 Sep;63(9):1182-5.
65. Norman Makous, Sidney Friedman, William Yakovac, Elizabeth P. Maris.. Cardiovascular manifestations in progeria. Report of clinical and pathologic findings in a patient with severe arteriosclerotic heart disease and aortic stenosis; American Heart Journal Volume 64, Issue 3, September 1962, Pages 334–346
66. Elizabeth G. Nabel; Cardiovascular Insights from a Premature Aging Syndrome: A Translational Story; Trans Am Clin Climatol Assoc. 2012; 123: 221–226.
67. Toshio Ogihara, Takeshi Hata, Kiyoji Tanaka, Kenichiro Fukuchi, Yoshi¬katsu Tabuchi, Yuichi Kumahara. Hutchinson-Gilford progeria syndrome in a 45-year-old man; The American Journal of Medicine; Volume 81, Issue 1, July 1986, Pages 135–138
68. Michelle Olive, Ingrid Harten, Richard Mitchell, Jeanette K. Beers, Karima Djabali. Cardiovascular Pathology in Hutchinson-Gilford Progeria: Correlation With the Vascular Pathology of Aging; Arteriosclerosis, Thrombosis, and Vas¬cular Biology. 2010; 30: 2301-2309.
69. William E. Stehbens, St.John Wakefield, Enid Gilbert-Barness, Robert E. Olson, Jeanne Ackerman. Histological and Ultrastructural Features of Athe¬rosclerosis in Progeria; Cardiovascular Pathology; Volume 8, Issue 1, January– February 1999, Pages 29–39
70. I H Maumenee. The eye in the Marfan syndrome; Trans Am Ophthalmol Soc. 1981; 79: 684–733. PMCID: PMC1312201
71. John C S Dean. Marfan syndrome: clinical diagnosis and management; European Journal of Human Genetics (2007) 15, 724–733
72. Aman Chandra, Victoria Ekwalla, Anne Child, and David Charteris. Pre¬valence of ectopia lentis and retinal detachment in Marfan syndrome; Acta Ophthalmologica; (February 2014) Volume 92, Issue 1, pages e82–e83
73. Ukponmwan CU. Ocular features and management challenges of Marfan's Syndrome in Benin City, Nigeria. Niger Postgrad Med J. 2013 Mar;20(1):24-8. PMID: 23661206.
74. Konradsen TR, Zetterström C. A descriptive study of ocular characteristics in Marfan syndrome; Acta Ophthalmol. 2013 Dec;91(8):751-5. doi: 10.1111/ aos.12068. Epub 2013 Feb 7.
75. Inge De Becker, David J. Gajda, Enid Gilbert-Barness and M. Michael Cohen Jr. Ocular manifestations in Proteus syndrome; American Journal of Medical Genetics; (June 2000) Volume 92, Issue 5, pages 350–352.
76. Evrydiki A. Bouzas, Donna Krasnewich, Michael Koutroumanidis, Alexan¬dros Papadimitriou. Ophthalmologic Examinadon in the Diagnosis of Proteus Syndrome; Ophthalmology; Volume 100, Issue 3, March 1993, Pages 334–338;
77. Trivedi D, Lee SY, Brundler MA, Parulekar MV. Fibrous tumor of the su¬perior oblique tendon in Proteus syndrome. J AAPOS. 2013 Aug;17(4):420-2.
78. Sánchez-López M, Martínez-Fernández R, Santamaría-Carro A. Ocular ma¬nifestations in Proteus syndrome; Arch Soc Esp Oftalmol. 2007 Mar;82(3):175- 8.
79. Sheard RM, Pope FM, Snead MP. .A novel ophthalmic presentation of the Proteus syndrome.; Ophthalmology. 2002 Jun;109(6):1192-5; PMID: 12045066
80. Bouzas EA, Krasnewich D, Koutroumanidis M, Papadimitriou A, Marini JC. Ophthalmologic examination in the diagnosis of Proteus syndrome; Ophthal-mology. 1993 Mar;100(3):334-8; PMID: 8460002
81. Gilbert-Barness E, Cohen MM Jr, Opitz JM. Multiple meningiomas, cranio¬facial hyperostosis and retinal abnormalities in Proteus syndrome; Am J Med Genet. 2000 Jul 31;93(3):234-40; PMID: 10925389
82. Shivcharan L Chandravanshi, Ashok Kumar Rawat, Prem Chand Dwivedi, and Pankaj Choudhary. Ocular manifestations in the Hutchinson-Gilford pro¬geria syndrome; PMC ID: PMC3214428; Indian J Ophthalmol. 2011 Nov-Dec; 59(6): 509–512.
83. Robert C. Moehlig. PROGERIA WITH NANISM AND CONGENITAL CATARACTS IN A FIVE YEAR OLD CHILD; JAMA. 1946;132(11):640-642.
84. V. V. Neroev, M. M. Archipova, L. E. Bakeeva, A. Zh. Fursova. Mitochon¬dria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals; Biochemistry (Moscow) December 2008, Volume 73, Issue 12, pp 1317-1328
85. Debette S, Germain DP. Neurologic manifestations of inherited disorders of connective tissue; Handb Clin Neurol. 2014;119:565-76.
86. Robert J. Wityk; Carla Zanferrari; Stephen Oppenheimer; Neurovascular Complications of Marfan Syndrome: A Retrospective, Hospital-Based Study; Stroke. 2002; 33: 680-684
87. J.S.P. van den Berg, M. Limburg, R.C.M. Hennekam. Is Marfan Syndrome Associated With Symptomatic Intracranial Aneurysms?; Stroke. 1996; 27: 10- 12
88. R E Pyeritz, E K Fishman, B A Bernhardt, and S S Siegelman. Dural ectasia is a common feature of the Marfan syndrome; Am J Hum Genet. Nov 1988; 43(5): 726–732; PMCID: PMC1715546
89. Iris Schrijver, Wouter I. Schievink, Maurice Godfrey, Fredric B. Meyer, and Uta Francke. Spontaneous spinal cerebrospinal fluid leaks and minor skeletal features of Marfan syndrome: a microfibrillopathy; Journal of Neuro¬surgery; March 2002 / Vol. 96 / No. 3 / Pages 483-489
90. R J Davenport, S J Chataway, C P Warlow. Spontaneous intracranial hypo¬tension from a CSF leak in a patient with Marfan's syndrome; J Neurol Neu¬rosurg Psychiatry 1995;59:516-519
91. W. Eugene Stern M.D; Dural ectasia and the Marfan syndrome; Journal of Neurosurgery; August 1988 / Vol. 69 / No. 2 / Pages 221-227
92. Tena Rosser, Julie Finkel, Gilbert Vezina, Massoud Majd. Case Report and Review of the Literature: Postural Headache in a Child With Marfan Syndro¬me; J Child Neurol February 2005 vol. 20 no. 2 153-155
93. J. D. Nelson. The Marfan Syndrome, with Special Reference to Congenital Enlargement of the Spinal Canal; The British Journal of Radiology: Volume 31 Issue 370, October 1958
94. Ahn, Nicholas U. Sponseller, Paul D, Ahn, Uri M; Nallamshetty, Leelakrish¬na BS; Kuszyk, Brian S; Zinreich, S. James et al. Case Study: Dural Ectasia Is Associated With Back Pain in Marfan Syndrome; Spine: 15 June 2000 - Volume 25 - Issue 12 - pp 1562-1568
95. P. D. Griffiths, R. J. Welch, D. Gardner-Medwin A. Gholkar, V. McAllister. The Radiological Features of Hemimegalencephaly Including Three Cases As¬sociated with Proteus Syndrome; Neuropediatrics 1994; 25(3): 140-144
96. Halisson Bastosa, Paula Fabiana Sobral da Silvaa, Marco Antônio Veloso de Albuquerquea, Adriana Mattosa, Rudimar Santos Riesgob, Lygia Ohlwei¬lerc. Proteus syndrome associated with hemimegalencephaly and Ohtahara syndrome: Report of two cases; Seizure; Volume 17, Issue 4, June 2008, Pages 378–382
97. Flemming Skovby, John M. Graham Jr., Stig Sonne-Holm, Dr. M. Michael, Cohen Jr. et al Compromise of the spinal canal in Proteus syndrome. Ameri¬can Journal of Medical Genetics; Volume 47, Issue 5, pages 656–659, 1 October 1993
98. Neil J. White, David D. Cochrane, and Richard Beauchamp. Paraparesis caused by an angiolipomatous hamartoma in an adolescent with Proteus syndrome and scoliosis; Journal of Neurosurgery: Pediatrics; September 2005 / Vol. 103 / No. 3 / Pages 282-284
99. R B Dietrich, D E Glidden, G M Roth, R A Martin and D S Demo. The Pro¬teus syndrome: CNS manifestations. American Journal of Neuroradiology: DOI: AJNR 1998 19: 987-990;
100. Sherman McCall, Magda I. Ramzy, Joel K. Cure and Dr. G. S. Pai. Encepha¬locraniocutaneous lipomatosis and the Proteus syndrome: Distinct entities with overlapping manifestations; American Journal of Medical Genetics: Volu¬me 43, Issue 4, pages 662–668, 1 July 1992
101. Sayama K.a, Hato N.b, Matsuda O.c, Shiraishi S.a, Miki Y.a et al. Case Report: Proteus Syndrome: ISSN: 1018-8665: Dermatology 1994;189:392–395
102. Manquillo A, Martínez-Mena J, Quintana P, Paradinas F, Sáez J, Revilla C, Galán JM. Neurophysiological aspects of Proteus syndrome. Et al. Rev Neurol. 1997 Oct;25(146):1572-4.
103. Nicole J. Ullrich, Mark W. Kieran, David T. Miller. Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment. Neurology July 30, 2013 vol. 81 no. 5 427-430
104. Marek Mandera, Dawid Larysz, Jacek Pajak, Andrzej Klimczak. Epidural hematomas in a child with Hutchinson-Gilford progeria syndrome; Child's Nervous System: January 2003, Volume 19, Issue 1, pp 63-65
105. M Plasilova, C Chattopadhyay, P Pal, N A Schaub, S A Buechner, Hj Mueller, P Miny, A Ghosh, K Heinimann. Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome; Letters to JMG; J Med Genet 2004;41:609-614
106. Gordon LB, Brown WT, Collins FS. Hutchinson-Gilford Progeria Syndrome. 2003 Dec 12 [Updated 2015 Jan 8]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015.
107. James R. Gossa, Donna Beer Stolzb, d, Andria Rasile Robinsonc. Pre¬mature aging-related peripheral neuropathy in a mouse model of progeria: Mechanisms of Ageing and Development; Volume 132, Issues 8–9, August– September 2011, Pages 437–442
108. V.M. Silveraa, L.B. Gordonb,d,e, D.B. Orbacha, S.E. Campbellf, J.T. Macha¬ne,g,h and N.J. Ullrichc et al Imaging Characteristics of Cerebrovascular Arte¬riopathy and Stroke in Hutchinson-Gilford Progeria Syndrome; Doi: 10.3174/ ajnr.A3341; AJNR 2013 34: 1091-1097
109. J R Wood, D Bellamy, A H Child, K M Citron. Pulmonary disease in patients with Marfan syndrome; Thorax 1984;39:780-784
110. Edward M. Dwyer Jr, and Frank Troncale. Spontaneous Pneumothorax and Pulmonary Disease in the Marfan Syndrome: Report of Two Cases and Review of the Literature; Ann Intern Med. 1965;62(6):1285-1292.
111. John R. Hall, Reed E. Pyeritz, David L. Dudgeon, J. Alex Haller Jr. Pneu¬mothorax in the Marfan Syndrome: Prevalence and Therapy; The Annals of Thoracic Surgery Volume 37, Issue 6, June 1984, Pages 500–504
112. Teoh PC. Bronchiectasis and spontaneous pneumothorax in Marfan's syndrome; Chest. 1977 Nov;72(5):672-3.
113. M. E. Foster and D. R. Foster. Bronchiectasis and Marfan's syndrome; Postgrad Med J. Oct 1980; 56(660): 718–719. PMCID: PMC2426010
114. E A Streeten; E A Murphy; R E Pyeritz. Pulmonary function in the Marfan syndrome; Chest. 1987;91(3):408-412. doi:10.1378/chest.91.3.408
115. J A Turner and N N Stanley. Fragile lung in the Marfan syndrome; Thorax. Dec 1976; 31(6): 771–775. PMCID: PMC470509
116. Andrew Jabbour, Saman Zaman, Tevfik Ismail, Sanjay Prasad, Prof Raad Mohiaddin. Profound pectus excavatum in Marfan's syndrome; The Lancet, Volume 379, Issue 9815, Page 557, 11 February 2012
117. Patricia L. Gordon, R. Sid Wilroy, Olga E. Lasater and Dr. M. Cohen Michael Jr. Neoplasms in proteus syndrome: American Journal of Medical Genetics: (May 1995) Volume 57, Issue 1, pages 74–78, 22
118. Rajeeva R Raju, William R Hart, David K Magnuson, Janet R Reid and Dou¬glas G, Rogers. Genital Tract Tumors in Proteus Syndrome: Report of a Case of Bilateral Paraovarian Endometrioid Cystic Tumors of Borderline Malignancy
and Review of the Literature; Mod Pathol 2002;15(2):172–180
119. Prasad Narayan, Rangaswamy Dharshan, Gupta Amit, Sharma Raj Kumar, Bhadauria Dharmender and Kaul Anupama. Distal renal tubular acidosis in a boy with Proteus syndrome; Kidney International (2013) 83, 1209–1210
120. Huang S, Liang Y, Wu W, Fu X, Liao L, Luo X. Analysis of a case with typical Hutchinson-Gilford progeria syndrome with scleroderma-like skin changes and review of literature. Zhonghua Er Ke Za Zhi. 2014 Feb;52(2):112-6.
121. Rork JF, Huang JT, Gordon LB, Kleinman M, Kieran MW, Liang MG. Initial cutaneous manifestations of hutchinson-gilford progeria syndrome; Pediatr Dermatol. 2014 Mar;31(2):196-202.
122. A. Harell Steinberg, A. Szeinberg, and B. E. Cohen. Amino-aciduria and Hypermetabolism in Progeria; Arch Dis Child. Oct 1957; 32(165): 401–403. PM¬CID: PMC2012178
123. Delahunt B, Stehbens WE, Gilbert-Barness E, Shozawa T, Rüger BM. Pro¬geria kidney has abnormal mesangial collagen distribution; Pediatr Nephrol. 2000
124. Graul-Neumann LM, Kienitz T, Robinson PN, Baasanjav S, Karow B, Gilles¬sen-Kaesbach G, Fahsold R, Schmidt H, Hoffmann K, Passarge E; Marfan syn¬drome
with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene.; American Journal of Medical Genetics Part A > Vol 152A Issue 11 > Abstract
125. Goldblatt J, Hyatt J, Edwards C, Walpole I. Further evidence for a mar¬fanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3' end of the FBN1 gene. American Journal of Medical Genetics Part A; (April 2011) Volume 155, Issue 4, pages 717–720
126. Takenouchi T, Hida M, Sakamoto Y, Torii C, Kosaki R, Takahashi T, Kosaki; Severe congenital lipodystrophy and a progeroid appearance: Mutation in the penultimate exon of FBN1 causing a recognizable phenotype. American Journal of Medical Genetics Part A; Volume 161, Issue 12, pages 3057–3062
127. Caux F, Dubosclard E, Lascols O, Buendia B, Chazouillères O, Cohen A et al. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukome¬lanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab. 2003 Mar;88(3):1006-13.
How to Cite
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to firstname.lastname@example.org
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to email@example.com